Mandatory Guidelines for Federal Workplace Drug Testing Program: Final Rule, Federal Register, 82 FR 7920 – 2017
This guidance explains the sciientific and technical guidelines for federal workplace drug-testing programs for urine testing.
Issued by: Substance Abuse and Mental Health Services (SAMHSA)
Issue Date: January 23, 2017
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.